These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15520044)

  • 1. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha.
    Donahue AC; Hess KL; Ng KL; Fruman DA
    Int Immunol; 2004 Dec; 16(12):1789-98. PubMed ID: 15520044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
    Maas A; Dingjan GM; Grosveld F; Hendriks RW
    J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.
    Kersseboom R; Kil L; Flierman R; van der Zee M; Dingjan GM; Middendorp S; Maas A; Hendriks RW
    Eur J Immunol; 2010 Sep; 40(9):2643-54. PubMed ID: 20623551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction.
    Suzuki H; Matsuda S; Terauchi Y; Fujiwara M; Ohteki T; Asano T; Behrens TW; Kouro T; Takatsu K; Kadowaki T; Koyasu S
    Nat Immunol; 2003 Mar; 4(3):280-6. PubMed ID: 12563258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
    EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling.
    Hoek KL; Carlesso G; Clark ES; Khan WN
    J Immunol; 2009 Nov; 183(9):5630-43. PubMed ID: 19843948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.
    Fruman DA; Ferl GZ; An SS; Donahue AC; Satterthwaite AB; Witte ON
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):359-64. PubMed ID: 11756681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
    Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C
    Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli.
    Donahue AC; Fruman DA
    Eur J Immunol; 2007 Oct; 37(10):2923-36. PubMed ID: 17724683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S; Hendriks RW
    J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
    Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
    Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen receptor proximal signaling in splenic B-2 cell subsets.
    Li X; Martin F; Oliver AM; Kearney JF; Carter RH
    J Immunol; 2001 Mar; 166(5):3122-9. PubMed ID: 11207264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 alters the antigen-driven selection of B cells in mukappa but not in mu-only Xid transgenic mice.
    Kenny JJ; Fischer RT; Lustig A; Dintzis H; Katsumata M; Reed JC; Longo DL
    J Immunol; 1996 Aug; 157(3):1054-61. PubMed ID: 8757609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct gene expression signature in Btk-defective T1 B-cells.
    Lindvall JM; Blomberg KE; Berglöf A; Smith CI
    Biochem Biophys Res Commun; 2006 Jul; 346(2):461-9. PubMed ID: 16764821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor.
    Eyquem S; Chemin K; Fasseu M; Chopin M; Sigaux F; Cumano A; Bories JC
    Eur J Immunol; 2004 Nov; 34(11):3187-96. PubMed ID: 15384043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
    Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
    Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.